About our reserch

About our reserch

Aiming to develop
a new generation BNCT.

Improvement of cancer-selective boron agents for personal BNCT, and utilization of efficient neutron generator are of paramount importance.

NTRC is collaborating with researchers worldwide
to establish secure and reliable BNCT procedure.

We aim to make BNCT to be one of the standard
cancer treatments.

RESEARCH ACHIEVEMENTS

RESEARCH PAPERS

2019

  • Kawabata T, Hiraki T, Iguchi T, Matsui Y,Uka M, Masaoka Y, Komaki T, Sakurai J, Gobara H, Araki M, Nasu Y, Kanazawa S.; Post-ablationsyndrome after percutaneous cryoablation of small renal tumors: A prospectivestudy of incidence, severity, duration, and effect on lifestyle. ; Eur JRadiol. 2020 Jan;122:108750.
  • Sadahira T, Wada K, Ikawa K, Morikawa N,Mitsui M, Araki M, Fujiyoshi M, Ishii A, Watanabe M, Watanabe T, Nasu Y.;Clinical pharmacokinetics of oral azithromycin in epididymal tissue. ; J InfectChemother. 2019 Oct;25(10):832-834.
  • Iwata T, Kimura S, Abufaraj M, Janisch F,Parizi MK, Haitel A, Rink M, Rouprêt M, Fajkovic H, Seebacher V, Nyirady P,Karakiewicz PI, Enikeev D, Rapoport LM, Nasu Y, Shariat SF.; Prognostic role ofthe urokinase plasminogen activator (uPA) system in patients with nonmuscleinvasive bladder cancer. ; Urol Oncol. 2019 Oct;37(10):774-783.
  • Iwata T, Kimura S, Abufaraj M, Janisch F,Karakiewicz PI, Seebacher V, Rouprêt M, Nasu Y, Shariat SF.; The role of adjuvantradiotherapy after surgery for upper and lower urinary tract urothelialcarcinoma: A systematic review. ; Urol Oncol. 2019 Oct;37(10):659-671.
  • Mitsui Y, Tomonobu N, Watanabe M, KinoshitaR, Sumardika IW, Youyi C, Murata H, Yamamoto KI, Sadahira T, Rodrigo AGH,Takamatsu H, Araki K, Yamauchi A, Yamamura M, Fujiwara H, Inoue Y, Futami J,Saito K, Iioka H, Kondo E, Nishibori M, Toyooka S, Yamamoto Y, Nasu Y,et al.; Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11Through Activation of Surrounding Fibroblasts. ; Oncol Res. 2019 Aug8;27(8):945-956.
  • Maruyama Y, Sadahira T, Araki M, Mitsui Y,Wada K, Edamura K, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.; Comparison of thepredictive value among inflammation-based scoring systems for bleomycinpulmonary toxicity in patients with germ cell tumors. ; Int JUrol.;26(8):813-819.
  • Kimura S, Iwata T, Foerster B, Fossati N,Briganti A, Nasu Y, Egawa S, Abufaraj M, Shariat SF.; Comparison ofperioperative complications and health-related quality of life betweenrobot-assisted and open radical cystectomy: A systematic review andmeta-analysis. ; Int J Urol.;26(8):760-774.
  • Iwata T, Kimura S, Foerster B, Fossati N,Briganti A, Karakiewicz PI, Gust KM, Egawa S, Nasu Y, Abufaraj M, ShariatSF.; Oncologic outcomes after robot-assisted versus open radical cystectomy: asystematic review and meta-analysis. ; World J Urol.;37(8):1557-1570.
  • Watanabe K, Katayama N, Katsui K,Matsushita T, Takamoto A, Ihara H, Nasu Y, Takemoto M, Kuroda M, Kanazawa S.;Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonanceimaging/computed tomography fusion image-based post-implant dosimetry ofprostate brachytherapy. ; J Radiat Res.;60(4):483-489.
  • Tsuboi I, Araki M, Fujiwara H, Iguchi T,Hiraki T, Arichi N, Kawamura K, Maruyama Y, Mitsui Y, Sadahira T, Kubota R,Nishimura S, Sako T, Takamoto A, Wada K, Kobayashi Y, Watanabe T, Yanai H,Kitagawa M, Tanabe K, Sugiyama H, Wada J, Shiina H, Kanazawa S, Nasu Y,et al.; Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablationof Renal Cell Carcinoma in a Renal Allograft: First Case in Asia. ; Acta Med Okayama.;73(3):269-272.
  • Tominaga Y, Sadahira T, Mitsui Y, MaruyamaY, Tanimoto R, Wada K, Munemasa S, Kusaka N, Nishiyama Y, Kurashige T, Nasu Y,Hayata S.; Favorable long-term oncological and urinary outcomes of incidentalprostate cancer following holmium laser enucleation of the prostate. ; Mol ClinOncol.;10(6):605-609.
  • Maruyama Y, Sadahira T, Araki M, Mitsui Y,Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.; Comparison oflongitudinal health-related quality-of-life outcomes between anterior andposterior surgical approaches to robot-assisted radical prostatectomy. ; JRobot Surg.
  • Uemura H, Uemura H, Nagamori S, Wakumoto Y,Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y,Yonese J, NasuY, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T,Matsubara N.; Three-year follow-up of a phase II study of radium-223 dichloridein Japanese patients with symptomatic castration-resistant prostate cancer andbone metastases. ; Int J Clin Oncol.;24(5):557-566.
  • Hakata Y, Michiue H, Ohtsuki T, MiyazawaM, Kitamatsu M.; A leucine zipper-based peptide hybrid delivers functionalNanog protein inside the cell nucleus.  ;Bioorg Med Chem Lett.;29(7):878-881..
  • Koyama t, Sasaki M, Hagiya H, Zamami Y,Funahashi T, Ohshima A, Tatebe Y, Mikami Y, Shinomiya K, Kitamura Y, Sendo T,Hinotsu S, Kano MR; Place of death trends among patients with dementia inJapan: a population-based observational study.,Scientific Reports, Vol.9, No.1,pp1-8.
  • Hagiya H, Koyama T, Zamami Y, Ttebe Y,Funahashi T, Shinomiya K, Kitamura Y, Hinotsu S, Sendo T, Rakugi H, Kano MR;Fall-related mortality trends in older Japanese adults aged ≥ 65 years: anationwide observational study., BMJ Open.;9(12):e033462.
  • Ohsima A, Koyama T, Ogawa A, Zamami Y, YutakaTakaguchi, Kitamura Y, Sendo T, Hinotsu S, Miller MW, Kano MR.;Oral anticoagulants usage in Japanese patients aged 18-74 years withnon-valvular atrial fibrillation: a retrospective analysis based on insuranceclaims data.,Fam Pract.;36(6):685-692
  • Watanabe S, Hayashi K, Toh K, Kim HJ, LiuX, Chaya H, Fukushima S, Katsushima K, Kondo Y, Uchida S, Ogura S, Nomoto T, TakemotoH, Cabral H, Kinoh H, Yutaka Takaguchi, Kano MR, Matsumoto Y, FukuharaH, Uchida S, Nangaku M, Osada K, Nishiyama N, Miyata K, Kataoka K.; In vivorendezvous of small nucleic acid drugs with charge-matched block catiomers totarget cancers., Nature communications, Vol10, No.1, pp1-13, (2019) ;
  • Teratani Y, Hagiya H, Koyama T, Ohshima A,Zamami Y, Tatebe Y, Tasaka K, Shinomiya K, Kitamura Y, Sendo T, Hinotsu S, Kano MR.;Association between rapid antigen detection tests and antibiotics for acutepharyngitis in Japan: A retrospective observational study.,Journal of Infectionand Chemotherapy, Vol25, No4,pp267-272.
  • Ken Aoo, Noriko Abe, Mitsunobu R Kano; To Be Supported, or Not to Be: Images of OlderPeople in Policy and the Reality in Local Communities in Japan.,Frontiers inSociology, Vol4, p.16.
  • Yutaka Takaguchi,Kitahara K, Sasaki N, Nakao N, Sato K, Narita H, Shimoda H, Matsusaki M,Nishihara H, Masamune A, Kano MR.; Pancreatic stellate cellsderived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECMremodeling in 3D engineered fibrotic tissue of clinically relevantthickness.,Biomaterials, Vol192, pp355-367.
  • Hiroyoshi Y Tanaka, Mitsunobu R Kano; Stromal Barriers Within the Tumor Microenvironmentand Obstacles to Nanomedicine.,Cancer Drug Delivery Systems Based on the TumorMicroenvironment,pp57-89.
  • Zamami Y, Niimura T, Koyama T, Shigemi Y,Izawa-Ishizawa Y, Morita M, Ohshima A, Harada K, Imai T, Hagiwara H, Okada N,Goda M, Takechi K, Chuma M, Kondo Y, Tsuchiya K, Hinotsu S, Kano MR,Ishizawa K.; Search for therapeutic agents for cardiac arrest using a drugdiscovery tool and large-scale medical information database.,Frontiers inPharmacology, Vol.10, p.1257.
  • Hagiya H, Koyama T, Zamami Y, Minato Y,Tatebe Y, Mikami N, Teratani Y, Ohshima A, Shinomiya K, Kitamura Y, Sendo T,Hinotsu S, Tomono K, Kano MR.; Trends in incidence andmortality of tuberculosis in Japan: a population-based study,1997?2016.,Epidemiology & Infection,Vol.147.」
  • Tomoyuki Tajima,* Rai Sanda, KatsuyaNishihara, Hitoshi Shirai, Yasuhiro Okuda, Akihiro Orita and YutakaTakaguchi; Disproportionation-induced solid-state fluorescence in6,13-dihydropentacenes; RSC Advances2019, 9, 17035-17039.
  • Yutaka Takaguchi,Hideaki Miyake, Takumi Izawa, Daiki Miyamoto, Ryohei Sagawa, Tomoyuki Tajima ; Molecular design of benzothiadiazole-based dyes for working withcarbon nanotube photocatalysts; Phosphorus,Sulfur, and Silicon and the Related Elements 2019, 194, 707-711.
  • TakumiIzawa, Vit Kalousek, Daiki Miyamoto, Noritake Murakami, Hideaki Miyake,Tomoyuki Tajima, Wataru Kurashige, Yuichi Negishi, Keita Ikeue, TakahiroOhkubo, and Yutaka Takaguchi; Carbon-Nanotube-based photocatalysts for WaterSplitting in Cooperation with BiVO4 and [Co(bpy)3]3+/2+; Chem. Lett., 5, 410-413.
  • Yutaka Takaguchi,Tomoyuki Tajima, Hideaki Miyake; Hydrogen-Evolving CNT-Photocatalysts forEffective Use of Solar Energy ; In: Nakashima N. (eds) Nanocarbons for EnergyConversion: Supramolecular Approaches.pp 205-218.Nanostructure Science and Technology. Springer, Cham
  • #Yamamoto T, #Fujimura A, Wei FY, ShinojimaN, Kuroda JI, Mukasa A, Tomizawa K. (#co-first); 2-MethylthioConversion of N6-Isopentenyladenosine in Mitochondrial tRNAs by CDK5RAP1Promotes the Maintenance of Glioma-Initiating Cells. ; iScience.;21:42-56.
  • Teratani Y, Hagiya H, Koyama T, Adachi M,Ohshima A, Zamami Y, Yutaka Takaguchi, Tatebe Y, Tasaka K,Mikami N, Shinomiya K, Kitamura Y, Kano MR, Hinotsu S, Sendo T; Pattern ofantibiotic prescriptions for outpatients with acute respiratory tractinfections in Japan, 2013-15: a retrospective observational study ; FamPract;36(4):402-409
  • Mon EE, Wei FY, Ahmad RNR, Yamamoto T,Moroishi T, Tomizawa K; Regulation of mitochondrial iron homeostasis bysideroflexin 2.; The journal of physiological sciences : J PhysiolSci.;69(2):359-373.
  • Abe T, La TM, Miyagaki Y, Oya E, Wei FY,Sumida K, Fujise K, Takeda T, Tomizawa K, Takei K, Yamada H; Phosphorylationof cortactin by cyclin-dependent kinase 5 modulates actin bundling by thedynamin 1-cortactin ring-like complex and formation of filopodia and lamellipodiain NG108-15 glioma-derived cells. ; Int J Oncol.;54(2):550-558
  • Nittaya WAKAI, Morihiro MAEDA, Toshiro ONO, TadashiHANAFUSA, Jun YAMASHITA and Kuniyuki SAITOH ; Radiocesium concentrationin stems, leaves, and panicles of rice grown in a sandy soil replacement paddyfield treated with different rates of cattle manure compost in Kawamata,Fukushima,  ; Journal of EnvironmentalScience for Sustainable Society (JESSS) 2019 Volume 9 Pages 1-10.
  • Tsai CH, Ting CC, Wu SY, Chiu JY, Chen H, Igawa K,Lan TH, Chen CM, Takato T, Hoshi K, Ko EC; Clinical significance of buccalbranches of the facial nerve and their relationship with the emergence ofStensen's duct: An anatomical study on adult Taiwanese cadavers.  ; Journal of cranio-maxillo-facial surgery : officialpublication of the European Association for Cranio-Maxillo-Facial Surgery47(11) 1809 – 1818.
  • Ichikawa, G., Tsuchida, K., Kiyanagi, Y.,Ishikawa, A., Hirata, Y., Yoshihashi, S., Watanabe, K., Uritani, A., Hamano,T., Ogawara, R., Suda, M., Igawa K.; Development of thermal neutronmoderator for testing boron agents for Boron Neutron Capture Therapy(BNCT)  ; JOURNAL OF INSTRUMENTATION 142019
  • Kirchner J, Schaarschmidt BM, Sauerwein W,Deuschl C, Arweiler-Harbeck D, Holtmann L, Stebner V, Umutlu L, Antoch G,Ruhlmann V. ; 18F-FDG PET/MRI versus MRI in patients with recurrentadenoid cystic carcinoma. ; Head Neck. 2019 Jan;41(1):170-176. doi:10.1002/hed.25485.
  • Ferrari E, Wittig A, Basilico F, Rossi R,De Palma A, Di Silvestre D, Sauerwein WAG, Mauri PL. ; UrinaryProteomics Profiles Are Useful for Detection of Cancer Biomarkers and ChangesInduced by Therapeutic Procedures. ; Molecules. ;22;24(4). pii: E794.
  • Yakushiji H, Kobayashi K, Takenaka F, KishiY, Shinohara M, Akehi M, Sasaki T, Ohno E, Matsuura E; Novel single-chain variant ofantibody against mesothelin established by phage library. ; Cancer Sci. 2019Sep; 110(9): 2722–2733.
  • Yoshiaki Kiyanagi, Yoshinori Sakurai, Hiroaki Kumada and Hiroki Tanaka,;  Status of accelerator-based BNCT projectsworldwide, AIP ; Conference Proceedings 2160, 050012 (2019);
  • Kitayama T, Akaki S, Hisazumi K, Yoshio K,Inoue D, Tajiri N, Shiode T, Kanazawa S, Fujimoto S, Kanai K, HirataY.; An Adult Case of Nasal Chondromesenchymal Hamartoma: ImagingCharacteristics Including Diffusion-Weighted Images. ; Acta MedOkayama.;73(6):529-532..
  • Komaki T, Hiraki T, Kamegawa T, Matsuno T,Sakurai J, Matsuura R, Yamaguchi T, Sasaki T, Mitsuhashi T, Okamoto S, Uka M,Matsui Y, Iguchi T, Gobara H, Kanazawa S.; Robotic CT-guided out-of-planeneedle insertion: comparison of angle accuracy with manual insertion in phantomand measurement of distance accuracy in animals. ; Eur Radiol.;30(3):1342-1349.
  • Katsui K, Ogata T,Watanabe K, Katayama N, Soh J, Kuroda M, Kiura K, Maeda Y, Toyooka S, Kanazawa S.; Dose-volumeparameters predict radiation pneumonitis after induction chemoradiotherapyfollowed by surgery for non-small cell lung cancer: a retrospective analysis. ;BMC Cancer. 26;19(1):1144. 019-6359-9.
  • Sugiyama S, Katsui K, Tominaga Y, Waki T,Katayama N, Matsuzaki H, Kariya S, Kuroda M, Nishizaki K, Kanazawa S.; Dose distributionof intensity-modulated proton therapy with and without a multi-leaf collimatorfor the treatment of maxillary sinus cancer: a comparative effectiveness study.; Radiat Oncol.  21;14(1):209.
  • Zhao Y, Matsui Y, Hiraki T, Iguchi T,Masaoka Y, Kanazawa S.; Six Cases of Radiographic Ice Ball Involvement ofthe Ureter During Percutaneous Cryoablation for Renal Cancers. ; CardiovascIntervent Radiol.;43(2):344-346.
  • Ihara H, Kaji T, Katsui K, Miyake T, Waki T,Katayama N, Matsuzaki H, Yamasaki O, Kuroda M, Morizane S, Kanazawa S.; Singleinstitutional experience of radiation therapy for angiosarcoma of the scalpwithout cervical lymph node metastases: Impact of concurrent chemoradiationwith maintenance chemotherapy using taxanes on patient prognosis. ; Mol ClinOncol. 2019 Nov;11(5):498-504.
  • Matsui Y, Sakurai J, Hiraki T, Okamoto S,Iguchi T, Tomita K, Uka M, Gobara H, Kanazawa S.; MRI-guided percutaneousneedle biopsy with 1.2T open MRI: study protocol for a prospective feasibilitystudy (SCIRO-1701). ; Nagoya J Med Sci.;81(3):463-468.
  • Yoshimura Y, Kuroda M, Sugianto I,Khasawneh A, Bamgbose BO, Hamada K, Barham M, Tekiki N, Kurozumi A, MatsushitaT, Ohno S, Kanazawa S, Asaumi J.; Development of a novel method forvisualizing restricted diffusion using subtraction of apparent diffusioncoefficient values. ; Mol Med Rep.;20(3):2963-2969.
  • Yoshio K, Wakita A, Hisazumi K, Kitayama T,Tajiri N, Shiode T, Akaki S, Kanazawa S.; Feasibility of 5-mm vs 2.5-mmwidth multileaf collimator in noncoplanar volumetric modulated arc stereotacticradiotherapy for multiple brain metastases. ; Med Dosim.;45(1):97-101.
  • Hiraki T, Kamegawa T, Matsuno T, Sakurai J,Komaki T, Yamaguchi T, Tomita K, Uka M, Matsui Y, Iguchi T, Gobara H, Kanazawa S.;Robotic needle insertion during computed tomography fluoroscopy-guided biopsy:prospective first-in-human feasibility trial. ; Eur Radiol.;30(2):927-933.
  • Yoshio K, Wakita A, Mitsuhashi T, KitayamaT, Hisazumi K, Inoue D, Tajiri N, Shiode T, Akaki S, Kanazawa S.; SimultaneousIntegrated Boost Volumetric Modulated Arc Therapy for Middle or LowerEsophageal Cancer Using Elective Nodal Irradiation: Comparison with 3DConformal Radiotherapy. ; Acta Med Okayama.;73(3):247-257.
  • Matsui Y, Fujiwara H, Hiraki T, Iguchi T,Komaki T, Tanaka T, Yagi T, Gobara H, Kanazawa S.; Histological findings innon-tumoral liver and tumor after chemoembolization with drug-eluting beads. ;Minim Invasive Ther Allied Technol.:1-7.
  • Hidaka H, Izumi N, Aramaki T, Ikeda M,Inaba Y, Imanaka K, Okusaka T, Kanazawa S, Kaneko S, Kora S, Saito H,Furuse J, Matsui O, Yamashita T, Yokosuka O, Morita S, Arioka H, Kudo M, AraiY.; Subgroup analysis of efficacy and safety of orantinib in combination withTACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL). ; MedOncol.;36(6):52.
  • Murai S, Sugiu K, Hishikawa T, Hiramatsu M,Nishihiro S, Takahashi Y, Date I; Endovascular treatment for unruptured aneurysm associated with persistentprimitive trigeminal artery :a care report and literature review ;  Acta Neurochirurgica (Wien) 161(2): 407-411
  • Ikawa F, Morita A, Tominari S, Nakayama T,Shiokawa Y, Date I, Nozaki K, Miyamoto S, Kayama T, Arai H, JapanNeurosurgical Society for UCAS Japan Investigators;  Rupture risk of small unruptured cerebralaneurysms ;  Journal of Neurosurgeryonline.
  • Hiramatsu M, Sugiu K, Yasuhara T, HishikawaT, Nishihiro S, Kidani N, Takahashi Y, Murai S, Date I;  Comparison between spinal dural arteriovenousfistula and spinal epidural arteriovenous fistula ;  Journal of Neuroendovascular Therapy13(3):114-119
  • Tomita Y, Kurozumi K, Yoo JY, Ichikawa T,Matsumoto Y, Uneda A, Hattori Y, Shimizu T, Otani Y, Oka T, Kaur B, Date I;  Oncolytic herpes virus armed withvasculostatin in combination with bevacizumab abrogate glioma invasion via theCCN1 and AKT signaling pathways ; Molecular Cancer Therapeutics 18(8):1418-1429
  • Shimizu T, Ishida J, Kurozumi K, IchikawaT, Otani Y, Oka T, Tomita Y, Hattori Y, Uneda A, Matsumoto Y, Date I;  δ-catenin promotes bevacizumab-induced gliomainvasion ;  Molecular Cancer Therapeutics18(4):812-822
  • Nishihiro S, Hishikawa T, Hiramatsu M,Kidani N, Takahashi Y, Murai S, Sugiu K, Higaki Y, Yasuhara T, Borlongan CV, Date I;  High-mobility group box-1-inducedangiogenesis after indirect bypass surgery in a chronic cerebral hypoperfusionmodel ;  Neuromoloecular Medicine
  • Kin K, Yasuhara T, Kawauchi S, Kameda M,Hosomoto K, Tomita Y, Umakoshi M, Kuwahara K, Kin I, Kidani N, Morimoto J,Sasaki T, DateI;  Lithium counteractsdepressive behavior and augments the treatment effect of selective serotoninreuptake inhibitor in treatment-resistant depressed rats ;  Brain Research 1717:52-59.
  • Kin K, Yasuhara T, Tomita Y, Umakoshi M, MorimotoJ, DateI;  SF-36 scores predictpostoperative delirium after surgery for cervical spondylotic myelopathy ;  Journal of Neurosurgery.
  • Tomita Y, Kurozumi K, Inagaki K, Kameda M,Ishida J, Yasuhara T, Ichikawa T, Sonoda T, Otsuka F, Date I;  Delayed postoperative hyponatremia afterendoscopic transsphenoidal surgery for pituitary adenoma ;  Acta Neurochirurgica (Wien) 161(4):707-715.
  • Kin K, Yasuhara T, Borlongan CV, Date I;  Encapsulated stem cells amelioratedepressive-like behavior via growth factor secretion ;  Brain Circulation 4(3):128-132.
  • Sasaki T, Kuwahara K, Kin I, Okazaki M,Sasada S, Shinko A, Kameda M, Yasuhara T, Agari T, Date I;  Identification of somatotopic organizationand optimal stimulation site within the subthalamic nucleus for Parkinson'sdisease ;  Operative Neurosurgery(Hagerstown, Md.) 17(3):239-246
  • Okuma Y, Wake H, Teshigawara K, TakahashiY, Hishikawa T, Yasuhara T, Mori S, Takahashi HK, Date I, Nishibori M;  Anti-high mobility group box 1 antibodytherapy may prevent cognitive dysfunction after traumatic brain injury ;  World Neurosurgery 122:e864-e871.
  • Hishikawa T, Sugiu K, Murai S, Takahashi Y,Kidani N, Nishihiro S, Hiramatsu M, Date I, Satow T, Iihara K, Sakai N,JR-NET2 and JR-NET 3 study groups;  Acomparison of the prevalence and risk factors of complications in intracranialtumor embolization between the Japanese Registry of NeuroEndovascular Therapy 2(JR-NET2) and JR-NET3 ;  ActaNeurochirurgica 161(8):1675-1682
  • Satoh T, Hishikawa T, Hiramatsu M, Sugiu K, Date I;  Visualization of aneurysmal neck and domeafter coiling with 3D multifusion imaging of silent MRA and FSE-MRcisternography ;  AJNR America Journal ofNeuroradiology 40(5):802-807
  • Tomita Y, Fujii K, Kurozumi K, Imoto R,Mitui T, Mishima S , Inagaki K, Masuyama H, Date I;  Cavernous malformation of the optic chiasmwith continuous hemorrhage in a pregnant woman :A case report ;  Interdisciplinary Neurosurgery 18.
  • Yasuhara T, Kawauchi S, Kin K, Morimoto J,Kameda M, Sasaki T, Bonsack B, Kingsbury C, Tajiri N, Borlongan CV, Date I;  Cell therapy for central nervous systemdisorders :Current obstacles to progress ; CNS Neuroscience & Therapeutics.
  • Koide Y, Osako T, Kameda M, Ihoriya H,Yamamoto H, Fujisaki N, Aokage T, Yumoto T, Date I, Naito H, Nakao A;  Huge abdominal cerebrospinal fluid pseudocystfollowing ventriculoperitoneal shunt :a case report ;  Journal of Medical Case Reports 13(1):361 .
  • Kin K, Yasuhara T, Kameda M, Date I;  Animal models for parkinson's diseaseresearch :Trends in the 2000s ; International Journal of Molecular Institute DOI: 10.3390/ijms20215402
  • Shear A, Nishihiro S, Hishikawa T,Hiramatsu M, Sugiu K, Yasuhara T, Date I; Cerebral circulation improves with indirect bypass surgery combined withgene therapy ;  Brain Circulation5(3):119-123.
  • Hiramatsu M, Sugiu K, Hishikawa T,Nishihiro S, Kidani N, Takahashi Y, Murai S, Date I, Kuwayama N, Satow T,Iihara K, Sakai N;  Results of 1940embolizations for dural arteriovenous fistulas :Japanese Registry ofNeuroendovascular Therapy (JR-NET3) ; Journal of Neurosurgery .
  • Sugiu K, Hishikawa T, Hiramatsu M,Nishihiro S, Kidani N, Takahashi Y, Murai S, Date I;  Endovascular treatment for craniofacialarteriovenous fistula/malformation ; Journal of Neuroendovascular 13(5):206-215
  • Sugiu K, Hishikawa T, Murai S, Takahashi Y,Kidani N, Nishihiro S, Hiramatsu M, Date I, Satow T, Iihara K, Sakai N;  Treatment outcome of intracranial tumorembolization in Japan :Japanese registry of neuroendovascular therapy 3(JR-NET3) ;  Neurologia medico-chirurgica  59(2):41-47
  • Uneda A, Hirashita K, Yunoki M, Yoshino K, Date I;  Pituitary adenoma apoplexy associated withvardenafil intake ;  Acta Neurochirurgica161(1):129-131
  • Satoh T, Yagi T, Onoda K, Kameda M, SasakiT, Ichikawa T, Date I;  Hemodynamicfeatures of offending vessels at neurovascular contact in patients withtrigeminal neuralgia and hemifacial spasm ; Journal of Neurosurgery 130(6):1870-1876
  • Otani Y, Ichikawa T, Kurozumi K, Date I;  Dynamic reorganization of microtubule andglioma invasion ;  Acta medica Okayama73(4):285-297
  • Matsumoto Y, Ichikawa T, Kurozumi K, OtaniY, DateI;  Clinicopathological andgenetic features of supratentorial cortical ependymomas ;  World Neurosurgery 129:e417-e428
  • Nishiyama K, Taira N, Mizoo T, Kochi M,Ikeda H, Iwamoto T, Shien T, Doihara H, Ishihara S, Kawai H, Kawasaki K, IshibeY, Ogasawara Y, Toyooka S.; Influence of breast density on breast cancer risk: acase control study in Japanese women. ; Breast Cancer. 2020 Mar;27(2):277-283.
  • Miyauchi S, Soh J, Shien K, Tanaka M,Yamamoto H, Ozaki T, Toyooka S.; Pulmonary resection in a proneposition for lung cancer invading the spine. ; Gen Thorac Cardiovasc Surg. 2020Mar;68(3):298-301..
  • Yamamoto H, Miyoshi K, Otani S, Kurosaki T,Sugimoto S, Yamane M, Toyooka S, Kobayashi M, Oto T.; Rightsingle lung transplantation using an inverted left donor lung: interposition ofpericardial conduit for pulmonary venous anastomosis - a case report. ; BMC PulmMed.;19;20(1):46.
  • Zhao Y, Matsui Y, Hiraki T, Iguchi T,Tomita K, Uka M, Gobara H, Toyooka S, Kanazawa S.; Computedtomography fluoroscopy-guided cutting needle biopsy of pulmonary nodules 竕、8 mm: A retrospective study including 117 nodules. ; Eur JRadiol.;125:108903.
  • Kurosaki T, Otani S, Miyoshi K, Okazaki M,Sugimoto S, Suno M, Yamane M, Kobayashi M, Oto T, Toyooka S.; Favorable survivaleven with high disease-specific complication rates in lymphangioleiomyomatosisafter lung transplantation-long-term follow-up of a Japanese center. ; ClinRespir J.;14(2):116-123..
  • Sugimoto S, Soh J, Suzawa K, Miyoshi K,Otani S, Yamamoto H, Okazaki M, Yamane M, Oto T, Kanazawa S, Kiura K, Toyooka S.;Pulmonary aspergillosis as a late complication after surgery for locallyadvanced non-small cell lung cancer treated with induction chemoradiotherapy. ;Surg Today.
  • Hirano Y, Sugimoto S, Yamamoto S, Okada M,Otani S, Ohara T, Yamane M, Matsukawa A, Oto T, Toyooka S.; Prolonged warmischemia exacerbated acute rejection after lung transplantation from donationafter cardiac death in a mouse. ; Gen Thorac Cardiovasc Surg. 2020Jan;68(1):57-62.
  • Takeda T, Yamamoto H, Suzawa K, Tomida S,Miyauchi S, Araki K, Nakata K, Miura A, Namba K, Shien K, Soh J, Shien T,Kitamura Y, Sendo T, Toyooka S.; YES1 activation inducesacquired resistance to neratinib in HER2-amplified breast and lung cancers. ;Cancer Sci.
  • Konishi Y, Miyoshi K, Kurosaki T, Otani S,Sugimoto S, Yamane M, Oto T, Toyooka S.; Airway bacteria of therecipient but not the donor are relevant to post-lung transplant pneumonia. ;Gen Thorac Cardiovasc Surg.
  • Hashimoto K, Yamane M, Sugimoto S, HiranoY, Kurosaki T, Otani S, Miyoshi K, Ohara T, Okazaki M, Yoshimura T, Oto T,Matsukawa A, Toyooka S.; Negative impact of recipient SPRED2 deficiency ontransplanted lung in a mouse model. ; Transpl Immunol.;57:101242.
  • Irie M, Otani S, Kurosaki T, Tanaka S, OhkiT, Miyoshi K, Sugimoto S, Yamane M, Oto T, Toyooka S.; Warm retrograde perfusion canremove more fat from lung grafts with fat embolism in a porcine model. ; GenThorac Cardiovasc Surg.
  • Soh J, Toyooka S, Okumura N, Nakamura H, NakataM, Yamashita M, Sakamoto J, Aoe M, Hotta K, Morita S, Date H.; Impact ofpathological stage and histological subtype on clinical outcome of adjuvantchemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur fornon-small cell lung cancer: subanalysis of SLCG0401 trial. ; Int J ClinOncol.;24(11):1367-1376.
  • Hamaji M, Sozu T, Machida R, Watanabe SI,Yoshida K, Toyooka S, Tanahashi M, Kondo K, Horio H, Okumura M, Date H.;Mortality from extrathymic malignancy after thymic tumour resections:incidences and risk factors. ; Interact Cardiovasc Thorac Surg.;29(5):729-736.
  • Makimoto G, Ohashi K, Tomida S, Nishii K,Matsubara T, Kayatani H, Higo H, Ninomiya K, Sato A, Watanabe H, Kano H,Ninomiya T, Kubo T, Rai K, Ichihara E, Hotta K, Tabata M, Toyooka S, Takata M, Maeda Y,Kiura K.; Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung CancerWith High Tumor Mutation Burden. ; J Thorac Oncol.;14(11):2009-2018.
  • Ogura T, Takigawa N, Tomii K, Kishi K,Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N,Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H,Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Toyooka S,et al.; Summary of the Japanese Respiratory Society statement for the treatmentof lung cancer with comorbid interstitial pneumonia. ; RespirInvestig.;57(6):512-533.
  • Endo S, Ikeda N, Kondo T, Nakajima J, KondoH, Shimada Y, Sato M, Toyooka S, Okada Y, Sato Y, Yoshino I,Okada M, Okumura M, Chida M, Fukuchi E, Miyata H.; Correction to: Riskassessments for broncho-pleural fistula and respiratory failure after lungcancer surgery by National Clinical Database Japan. ; Gen Thorac CardiovascSurg.;67(10):904-906..
  • Makimoto G, Ohashi K, Taniguchi K, Soh J,Taniguchi A, Miyahara N, Toyooka S, Yoshino T, Maeda Y, Kiura K.;Long-term spontaneous remission with active surveillance in IgG4-relatedpleuritis: A case report and literature review. ; Respir Med CaseRep.;28:100938..
  • Takahashi Y, Iwamoto T, Suzuki Y, KajiwaraY, Hatono M, Tsukioki T, Kawada K, Kochi M, Ikeda H, Shien T, Taira N, MatsuokaJ, Doihara H, Toyooka S.; Evaluation of Therapeutic Target Gene ExpressionBased on Residual Cancer Burden Classification After Neoadjuvant Chemotherapyfor HER2-Negative Breast Cancer. ; Clin Breast Cancer. pii:S1526-8209(19)30643-3.
  • Yoshioka T, Shien K, Takeda T, Takahashi Y,Kurihara E, Ogoshi Y, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Soh J,Fujiwara T, Toyooka S.; Acquired resistance mechanisms to afatinib inHER2-amplified gastric cancer cells. ; Cancer Sci.;110(8):2549-2557.
  • Ninomiya K, Hata T, Yoshioka H, Ohashi K,Bessho A, Hosokawa S, Ishikawa N, Yamasaki M, Shibayama T, Aoe K, Kozuki T,Harita S, Ueda Y, Murakami T, Fujimoto N, Yanai H, Toyooka S, Takata M, Hotta K,Kiura K; HER2-CS Network..; A Prospective Cohort Study to Define the ClinicalFeatures and Outcome of Lung Cancers Harboring HER2 Aberration in Japan(HER2-CS STUDY). ; Chest.;156(2):357-366.
  • Sugimoto S, Yamamoto H, Kurosaki T, OtaniS, Okazaki M, Yamane M, Toyooka S, Oto T.; Impact of chronic lungallograft dysfunction, especially restrictive allograft syndrome, on thesurvival after living-donor lobar lung transplantation compared with cadavericlung transplantation in adults: a single-center experience. ; SurgToday.;49(8):686-693.
  • Kinoshita R, Sato H, Yamauchi A, TakahashiY, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S,Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J,Putranto EW, Ruma IMW, Yamamoto H, Soh J, Toyooka S, et al.; Newly developedanti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancermetastasis. ; Int J Cancer.;145(2):569-575.
  • Chen Y, Sumardika IW, Tomonobu N, KinoshitaR, Inoue Y, Iioka H, Mitsui Y, Saito K, Ruma IMW, Sato H, Yamauchi A, Murata H,Yamamoto KI, Tomida S, Shien K, Yamamoto H, Soh J, Futami J, Kubo M, PutrantoEW, Murakami T, Liu M, Toyooka S, et al.; Critical role of theMCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast canceraggressiveness. ; Neoplasia.;21(7):627-640.
  • Suzawa K, Soh J, Takahashi Y, Sato H, ShienK, Yamamoto H, Kanazawa S, Kiura K, Miyoshi S, Toyooka S.; Clinical outcome ofpatients with recurrent non-small cell lung cancer after trimodality therapy. ;Surg Today.;49(7):601-609.
  • Chen Y, Sumardika IW, Tomonobu N, WinarsaRuma IM, Kinoshita R, Kondo E, Inoue Y, Sato H, Yamauchi A, Murata H, YamamotoKI, Tomida S, Shien K, Yamamoto H, Soh J, Liu M, Futami J, Sasai K, Katayama H,Kubo M, Putranto EW, Hibino T, Toyooka S, et al.; Melanoma cell adhesionmolecule is the driving force behind the dissemination of melanoma uponS100A8/A9 binding in the original skin lesion. ; Cancer Lett.;452:178-190.
  • Takamatsu H, Yamamoto KI, Tomonobu N, MurataH, Inoue Y, Yamauchi A, Sumardika IW, Chen Y, Kinoshita R, Yamamura M, FujiwaraH, Mitsui Y, Araki K, Futami J, Saito K, Iioka H, Ruma IMW, Putranto EW,Nishibori M, Kondo E, Yamamoto Y, Toyooka S, et al.; Extracellular S100A11Plays a Critical Role in Spread of the Fibroblast Population in PancreaticCancers. ; Oncol Res.;27(6):713-727.
  • Kinoshita R, Sato H, Yamauchi A, TakahashiY, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S,Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J,Putranto EW, Ruma IMW, Yamamoto H, Soh J, Toyooka S, et al.; exSSSRs (extracellularS100 soil sensor receptors)-Fc fusion proteins work as prominent decoys toS100A8/A9-induced lung tropic cancer metastasis. ; Int J Cancer.;144(12):3138-3145.
  • Sato H, Soh J, Aoe K, Fujimoto N, Tanaka S,Namba K, Torigoe H, Shien K, Yamamoto H, Tomida S, Tao H, Okabe K, Kishimoto T, ToyookaS.; Droplet digital PCR as a novel system for the detection ofmicroRNA-34b/c methylation in circulating DNA in malignant pleuralmesothelioma. ; Int J Oncol.;54(6):2139-2148.
  • Sumardika IW, Chen Y, Tomonobu N, KinoshitaR, Ruma IMW, Sato H, Kondo E, Inoue Y, Yamauchi A, Murata H, Yamamoto KI,Tomida S, Shien K, Yamamoto H, Soh J, Futami J, Putranto EW, Hibino T,Nishibori M, Toyooka S, Sakaguchi M.; Neuroplastin-β mediates S100A8/A9-inducedlung cancer disseminative progression. ; Molecular carcinogenesis.58(6) :980 - 995
  • Mesaki K, Yamane M, Sugimoto S, Fujisawa M,Yoshimura T, Kurosaki T, Otani S, Miyoshi S, Oto T, Matsukawa A, Toyooka S.;SOCS3 overexpression in T cells ameliorates chronic airway obstruction in amurine heterotopic tracheal transplantation model. ; Surg Today.;49(5):443-450.
  • Kurihara E, Shien K, Torigoe H, Takeda T,Takahashi Y, Ogoshi Y, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, SohJ, Okazaki M, Shien T, Tomida S, Toyooka S.; Ganetespib in Epidermal GrowthFactor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer.; Anticancer Res.;39(4):1767-1775.
  • Hashimoto M, Shirakawa Y, Maeda N, TanabeS, Noma K, Sakurama K, Katsui K, Nishizaki M, Fujiwara T.;Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracilfor locally advanced esophageal cancer. ; Esophagus.
  • Niibe Y, Yamamoto T, Onishi H, Yamashita H, Katsui K,Matsumoto Y, Oh RJ, Aoki M, Shintani T, Yamada K, Kobayashi M, Ozaki M, ManabeY, Yahara K, Nishikawa A, Kakuhara H, Yamamoto K, Inoue T, Takada YU, Nagata K,Suzuki O, Terahara A, et al.; Pulmonary Oligometastases Treated by StereotacticBody Radiation Therapy: A Nationwide Survey of 1,378 Patients. ; AnticancerRes.;40(1):393-399.

2018

  • Sadahira T, Mitsui Y, Araki M, Maruyama Y, Wada K, Edamura K, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.; Pelvic magnetic resonance imaging parameters predict urinary incontinence after robot-assisted radical prostatectomy. ; Low Urin Tract Symptoms.;11(3):122-126.
  • Nishimura S, Wada K, Araki M, Sadahira T, Maruyama Y, Mitsui Y, Tanimoto R, Kobayashi Y, Watanabe T, Nasu Y.; Use of single-dose perioperative antimicrobial therapy is acceptable in recipients of living-donor renal transplants in the rituximab era. ; J Infect Chemother.;25(4):247-252.
  • Iwata T, Kimura S, Foerster B, Abufaraj M, Karakiewicz PI, Preisser F, Nasu Y, Shariat SF.; Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis. ; Urol Oncol.;37(4):273-281.
  • Xu N, Huang L, Li X, Watanabe M, Li C, Xu A, Liu C, Li Q, Araki M, Wada K, Nasu Y, Huang P.; The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer. ; Int J Biol Sci.;15(5):919-928.
  • Mitsui Y, Sadahira T, Araki M, Maruyama Y, Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.; Clinical impact of abdominal fat distribution measured by 3-D computed tomography volumetry on post-transplant renal function in recipients after living kidney transplantation: a retrospective study. ; Clin Exp Nephrol.;23(3):415-424.
  • Sadahira T, Wada K, Nasu Y.; Editorial Comment from Dr Sadahira et al. to Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study ; Int J Urol.;26(3):399.
  • Mitsui Y, Sadahira T, Araki M, Maruyama Y, Nishimura S, Wada K, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.; The 3-D Volumetric Measurement Including Resected Specimen for Predicting Renal Function AfterRobot-assisted Partial Nephrectomy. ; Urology.;125:104-110.
  • Oiwa Y, Watanabe T, Sadahira T, Ishii A, Sako T, Inoue M, Wada K, Kobayashi Y, Araki M, Nasu Y.; Clitoral Blood Flow Changes after Surgery with Tension-Free Vaginal Mesh for Pelvic Organ Prolapse. ; Acta Med Okayama.;73(1):21-27.
  • Mitsui Y, Sadahira T, Araki M, Maruyama Y, Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.; Loss of psoas major muscle volume during systemic chemotherapy is related to worse prognosis in testicular cancer. ; Jpn J Clin Oncol.;49(2):183-189.
  • Mitsui Y, Sadahira T, Maruyama Y, Wada K, Tanimoto R, Sugimoto M, Araki M, Watanabe M, Yanai H, Watanabe T, Nasu Y.; Burned-out Prostate Cancer ? Primary Metastatic Cancer Not Detected on Repeat Biopsy. ; Acta Med Okayama.;72(6):605-609.
  • Xu N, Li X, Watanabe M, Ueki H, Hu H, Li N, Araki M, Wada K, Xu A, Liu C, Nasu Y, Huang P.; Induction of cells with prostate cancer stem-like properties from mouse induced pluripotent stem cells via conditioned medium. ; Am J Cancer Res.;8(8):1624-1632..
  • Kambara T, Tanimoto R, Araki M, Saika T, Hashimoto H, Oeda T, Tsushima T, Hayata S, Nasu Y, Kobayashi Y.; Renal Function after Nephrectomy Influences the Risk of Cardiovascular Events. ; Acta Med Okayama.;72(3):241-247.
  • Tanimoto R, Saika T, Ebara S, Kobayashi Y, Nasu R, Yamada D, Takamoto H, Miyaji Y, Nasu Y, Tsushima T, Kumon H.; Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation. ; World J Urol.;36(6):889-895..
  • Takamoto A, Tanimoto R, Bekku K, Araki M, Sadahira T, Wada K, Ebara S, Katayama N, Yanai H, Nasu Y.; Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer. ; Int J Urol.;25(5):507-512.
  • Maruyama Y, Sadahira T, Mitsui Y, Araki M, Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.; Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors. ; Med Oncol.;35(6):80.
  • Otani Y, Ichikawa T, Kurozumi K, Inoue S, Ishida J, Oka T, Shimizu T, Tomita Y, Hattori Y, Uneda A, Matsumoto Y, Michiue H, Date I.; Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion ; Oncogene.;37(6):777-786.
  • Latt HM, Matsushita H, Morino M, Koga Y, Michiue H, Nishiki T, Tomizawa K, Matsui H.; Oxytocin Inhibits Corticosterone-induced Apoptosis in Primary Hippocampal Neurons. ; Neuroscience.;379:383-389.
  • Shiba H, Takeuchi K, Hiramatsu R, Furuse M, Nonoguchi N, Kawabata S, Kuroiwa T, Kondo N, Sakurai Y, Suzuki M, Ono K, Oue S, Ishikawa E, Michiue H, Miyatake SI.; Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas - A Pilot Study.  ; Neurol Med Chir (Tokyo).;58(12):487-494.
  • Teratani Y, Hagiya H, Koyama T, Adachi M, Ohshima A, Zamami Y, Tanaka HY, Tatebe Y, Tasaka K, Mikami N, Shinomiya K, Kitamura Y, Kano MR, Hinotsu S, Sendo T.; Pattern of antibiotic prescriptions for outpatients with acute respiratory tract infections in Japan, 2013-15: a retrospective observational study.,Family practice, Vol36, No.4, pp402-409.
  • Onoue H, Koyama T, Zamami Y, Hagiya H, Tatebe Y, Mikami N, Shinomiya K, Kitamura Y, Hinotsu S, Sendo T, Ouchi Y, Kano MR.; Trends in polypharmacy in Japan: a nationwide retrospective study.,JOURNAL OF THE AMERICAN GERIATRIC SCIETY,Vol.66,No.12.
  • Tanaka, Hiroyoshi Y.;Kano, Mitsunobu R.; Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment,CANCER SCIENCE,Vol.109,No.7,pp.2085-2092.
  • Nishiguchi, Akihiro;Matsusaki, Michiya;Kano, Mitsunobu R.;Nishihara, Hiroshi;Okano, Daisuke;Asano, Yoshiya;Shimoda, Hiroshi;Kishimoto, Satoko;Iwai, Soichi;Akashi, Mitsuru; In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis,BIOMATERIALS,Vol.179,pp.144-155.
  • Niimura T, Zamami Y, Koyama T, Izawa-Ishizawa Y, Miyake M, Koga T, Harada K, Ohshima A, Imai T, Kondo Y, Imanishi M, Takechi K, Fukushima K, Horinouchi Y, Ikeda Y, Fujino H, Tsuchiya K, Tamaki T, Hinotsu S, Kano MR, Ishizawa K.; Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest.,SCIETIFIC REPORTS,Vol.7,No.1.
  • Kano, Mitsunobu R.;Tanaka, Hiroyoshi Y.; Developing experimental models to analyze the behavior of Nano-DDSs within biological systems,CANCER SCIENCE,Vol.109,p.148.
  • Baba, Yoshinobu;Kano, Mitsunobu; Application of biomaterials in interdisciplinary approaches for cancer research,CANCER SCIENCE,Vol.109,p.146.
  • Fakruddin M, Wei FY, Suzuki T, Asano K, Kaieda T, Omori A, Izumi R, Fujimura A, Kaitsuka T, Miyata K, Araki K, Oike Y, Scorrano L, Suzuki T, Tomizawa K. ; Defective Mitochondrial tRNA Taurine Modification Activates Global Proteostress and Leads to Mitochondrial Disease. ; Cell Rep. 22(2):482-496.
  • Wei FY, Tomizawa K; tRNA modifications and islet function. ; Diabetes Obes Metab.;20 Suppl 2:20-27.
  • Sakakida K, Wei FY, Senokuchi T, Shimoda S, Kakuma T, Araki E, Tomizawa K, Eperisone for, Diabetes with, Impaired tRNA (EDIT) Study Group; Study Design of a Phase II Clinical Trial to Assess the Efficacy and Safety of Eperisone in Japanese Type 2 Diabetes Patients with Risk and Non-risk Alleles of CDKAL1.; Acta Med Okayama.;72(4):423-426.
  • Futakuchi A, Inoue T, Wei FY, Inoue-Mochita M, Fujimoto T, Tomizawa K, Tanihara H; YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis. ; Invest Ophthalmol Vis Sci. ;59(7):3069-3078.
  • Rosati R, Polin L, Ducker C, Li J, Bao X, Selvakumar D, Kim S, Xhabija B, Larsen M, McFall T, Huang Y, Kidder BL, Fribley A, Saxton J, Kakuta H, Shaw P, Ratnam M.; Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer.   ; lin Cancer Res.;24(24):6509-6522.
  • Watanabe M, Kakuta H. ; Retinoid X Receptor Antagonists.  ; Int J Mol Sci.;19(8). pii: E2354.
  • Nittaya WAKAI, Jun YAMASHITA, Takashi ENOMOTO, Tadashi HANAFUSA, Toshiro ONO, Morihiro MAEDA  ; Factors affecting 137Cs concentration in wild plants and soils of?different land use in Iitate village after the Fukushima nuclear power?plant accident. ; Radiaiton Safety Management 2018 Volume 18 Pages 1-8.
  • Sauerwein W, Matsui H, Tsuchida K, Kiyanagi Y, Igawa K, Furuya S, Ichikawa Y; The Okayama-Nagoya BNCT Project, ; Strahlender Onkol, 194 (Suppl.1), S100-S101.
  • Stöckel E, Eichmann M, Flühs D, Sommer H, Biewald E, Bornfeld N, Spaan B, Sauerwein W..; Dose distributions and treatment margins in ocular brachytherapy with 106Ru eye plaques. ; Ocul Oncol Pathol 4:122-128.
  • Renate Petersen; Ruth Grümmer; Verena Jendrossek; Wolfgang Sauerwein; Ulrike Schara; Mentoring in a medical faculty: a chance for organisational learning ; International Journal of Learning and Change, 2018 Vol.10 No.3, pp.198 – 219.
  • Lianhua Shen, Nuriza Ulul Azmi, Xian Wen Tan, Shinsuke Yasuda, Arum Tri Wahyuningsih, Junko Inagaki, Kazuko Kobayashi, Eiji Ando, Takanori Sasaki, Eiji Matsuura; Mutants of β2-glycoprotein I: Their features and potent applications. ; Best Pract Res Clin Rheumatol.;32(4):572-590.
  • Ames PRJ, Lopez LL, Merashli M, Matsuura E. Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome. Auto Immun Highlights.;9(1):2.
  • Shinya T, Masaoka Y, Sando M, Tanabe S, Okamoto S, Ihara H, Tanaka T, Otani S, Hiraki T, Kanazawa S.; Imaging an intrapulmonary solitary fibrous tumor with CT and F-18 FDG PET/CT. ; Radiol Case Rep.;14(6):755-758.
  • Suzawa K, Soh J, Takahashi Y, Sato H, Shien K, Yamamoto H, Kanazawa S, Kiura K, Miyoshi S, Toyooka S.; Clinical outcome of patients with recurrent non-small cell lung cancer after trimodality therapy. ; Surg Today.;49(7):601-609.
  • Matsuoka H, Nakamura K, Matsubara Y, Ida N, Nishida T, Ogawa C, Katsui K, Kanazawa S, Masuyama H.; Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy. ; Anticancer Res.;39(2):933-939.
  • Hiraki T, Kamegawa T, Matsuno T, Komaki T, Sakurai J, Kanazawa S.; ZerobotR: A Remote-controlled Robot for Needle Insertion in CT-guided Interventional Radiology Developed at Okayama University. ; Acta Med Okayama.;72(6):539-546.
  • Okawa H, Gobara H, Matsui Y, Iguchi T, Hiraki T, Kanazawa S.; Ureteral obstruction by sloughed tumor complicating cryoablation of a renal oncocytoma. ; Radiol Case Rep.;13(6):1195-1198.
  • Ogata T, Katsui K, Yoshio K, Ihara H, Katayama N, Soh J, Kuroda M, Kiura K, Maeda Y, Toyooka S, Kanazawa S.; Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer. ; Acta Med Okayama.;72(5):507-513.
  • Miyahara K, Kuroda M, Yoshimura Y, Aoyama H, Oita M, Sugianto I, Matsuzaki H, Ihara H, Katayama N, Katsui K, Kanazawa S, Asaumi J.; Evaluation of Setup Errors at the Skin Surface Position for Whole Breast Radiotherapy of Breast Cancer Patients. ; Acta Med Okayama.;72(4):331-336.
  • Shinya T, Tada A, Masaoka Y, Ogawa N, Makimoto S, Ihara H, Fukuhara R, Akagi N, Hiraki T, Nakao A, Kanazawa S.; A rapid caliber change in the inferior vena cava during multiphasic contrast-enhanced computed tomography may signal an acute anaphylactic reaction to nonionic contrast medium. ; Radiol Case Rep.;13(5):970-974.
  • Shimizu T, Hishikawa T, Nishihiro S, Shinji Y, Takasugi Y, Haruma J, Hiramatsu M, Kawase H, Sato S, Mizoue R, Takeda Y, Sugiu K, Morimatsu H, Date I;  NADH fluorescence imaging and the histological impact of cortical spreading depolarization during the acute phase of subarachnoid hemorrhage in rats ;  Journal of Neurosurgery 128(1):137-143
  • Umakoshi M, Yasuahra T, Toyoshima A, Sasada S, Kusumegi A, Morimoto J, Kin K, Tomita Y, Date I;  Spinal Extradural arachnoid cyst :Significance of intrathecal infusion after fistula closure ;  Acta Medica Okayama 72(1): 73-76.
  • Takahashi Y, Sugiu K, Haruma J, Murai S, Kidani N, Nishihiro S, Hiramatsu M, Hishikawa T, Date I;  Ex vivo release of pipeline embolization device polytetrafluoroethylene sleeves :a technical note ;  Journal of Neuroendovascular Therapy 12(9):463-468
  • Nishihiro S, Sugiu K, Hishikawa T, Hiramatsu M, Kidani N, Takahashi Y, Date I;  Outcome of coil embolization for symptomatic unruptured cerebral aneurysms ;  Journal of Neuroendovascular Therapy 12(4):169-174
  • Morimoto J, Yasuhara T, Kameda M, Umakoshi M, Kin I, Kuwahara K, Kin K, Okazaki M, Takeuchi H, Sasaki T, Toyoshima A, Tajiri N, Agari T, Borlongan CV, Date I;  Electrical stimulation enhances migratory ability of transplanted bone marrow stromal cells in a rodent ischemic stroke model ;  Cellular Physiology and Biochemistry 46(1):57-68
  • Takeuchi H, Kameda M, Yasuhara T, Sasaki T, Toyoshima A, Morimoto J, Kin K, Okazaki M, Umakoshi M, Kin I, Kuwahara K, Tomita Y, Date I;  Long-term potentiation enhances neuronal differentiation in the chronic hypoperfusion model of rats ;  Frontiers in Aging Neuroscience;10:29.
  • Murai S, Sugiu K, Hishikawa T, Hiramatsu M, Nishihiro S, Kidani N, Takahashi Y, Date I;  Coil embolization through collateral pathway for ruptured vertebral artery dissecting aneurysm with bilateral vertebral artery occlusion ;  Journal of Stroke & Cerebrovascular Idseases 27(9):e215-e218.
  • Matsumoto N, Sato K, Tadokoro K, Takahashi Y, Yunoki T, Takemoto M, Hishikawa N, Ohta Y, Yamashita T, Fujii K, Ichikawa T, Date I, Abe K;  A case of aspergillotic orbital apex syndrome diagnosed by an additional intraorbital biopsy after nasal endoscopy ;  Neurology and Clinical Neuroscience 6(6):188-190.
  • Kin K, Yasuhara T, Kameda M, Tomita Y, Umakoshi M, Kuwahara K, Kin I, Kidani N, Morimoto J, Okazaki M, Sasaki T, Tajiri N, BorlonganCV, Date I;  Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats ;  Molecular Psychiatry.
  • Sasaki R, Ohta Y, Yamada Y, Tadokoro K, Takahashi Y, Sato K, Shang J, Takemoto M, Hishikawa N, Yamashita T, Yasuhara T, Date I, Ikegawa S, Fujii N, Abe K;  Neurolymphomatosis in the cauda equina diagnosed by an open biopsy ;  Internal Medicine 57(23):3463-3465.
  • Okazaki M, Sasaki T, Yasuhara T, Kameda M, Agari T, Kin I, Kuwahara K, Morimoto J, Kin K, Umakoshi M, Tomita Y, Borlongan CV, Date I;  Characteristics and prognostic factors of Parkinson's disease patients with abnormal postures subjected to subthalamic nucleus deep brain stimulation ;  Parkinsonism & Related Disorders 57:44-49.
  • Sasaki T, Agari T, Kuwahara K, Kin I, Okazaki M, Sasada S, Shinko A, Kameda M, Yasuhara T, Date I;  Efficacy of dural sealant system for preventing brain shift and improving accuracy in deep brain stimulation surgery ;  Neurologia medico-chirurgica (Tokyo) 58(5): 199-205.
  • Kin K, Agari T, Yasuhara T, Tomita Y, Kuwahara K, Kin I, Umakoshi M, Morimoto J, Okazaki M, Sasaki T, Date I;  The factors affecting the difficulty of percutaneous cylindrical electrode placement for spinal cord stimulation ;  World Neurosurgery 113: e391-e398.
  • Otani Y, Ichikawa T, Uneda A, Kurozumi K, Ishida J, Date I;  Comparative histologic and molecular analysis of 2 recurrent lesions showing different magnetic resonance imaging responses after bevacizumab treatment :Report of a case of anaplastic astrocytoma ;  World Neurosurgery 116:464-471.
  • Otani Y, Kurozumi K, Ishida J, Hiramatsu M, Kameda M, Ichikawa T, Date I;  Combination of the tubular retractor and brain spatulas provides an adequate operative field in surgery for deep-seated lesions :Case series and technical note ;  Surgical Neurology International 9:220.
  • Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Shimada Y, Sato M, Toyooka S, Okada Y, Sato Y, Yoshino I, Okada M, Okumura M, Chida M, Fukuchi E, Miyata H.; Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan. ; Gen Thorac Cardiovasc Surg.;67(3):297-305.
  • Ogoshi Y, Shien K, Yoshioka T, Torigoe H, Sato H, Sakaguchi M, Tomida S, Namba K, Kurihara E, Takahashi Y, Suzawa K, Yamamoto H, Soh J, Toyooka S.; Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations. ; Oncol Lett.;17(3):2729-2736.
  • Tanaka S, Miyoshi K, Higo H, Kurosaki T, Otani S, Sugimoto S, Yamane M, Kiura K, Toyooka S, Oto T.; Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival. ; Respir Investig.;57(2):165-171.
  • Sugimoto S, Kurosaki T, Otani S, Tanaka S, Hikasa Y, Yamane M, Toyooka S, Kobayashi M, Oto T.; Feasibility of lung transplantation from donors mechanically ventilated for prolonged periods. ; Surg Today.;49(3):254-260.
  • Yamamoto H, Sugimoto S, Tanaka S, Kurosaki T, Otani S, Yamane M, Taira N, Oto T, Toyooka S.; A single-nucleotide polymorphism in a gene modulating glucocorticoid sensitivity is associated with the decline in total lung capacity after lung transplantation. ; Surg Today.;49(3):268-274.
  • Namba K, Tomida S, Matsubara T, Takahashi Y, Kurihara E, Ogoshi Y, Yoshioka T, Takeda T, Torigoe H, Sato H, Shien K, Yamamoto H, Soh J, Tsukuda K, Toyooka S. Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma. BMC Cancer.;19(1):175.
  • Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Date H, Yokoi K, Asamura H, Nagayasu T, Miyaoka E, Yoshino I; Japanese Joint Committee of Lung Cancer Registry..; Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010. ; J Thorac Oncol.;14(2):212-222..
  • Namba K, Shien K, Takahashi Y, Torigoe H, Sato H, Yoshioka T, Takeda T, Kurihara E, Ogoshi Y, Yamamoto H, Soh J, Tomida S, Toyooka S.; Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells. ; Mol Cancer Res.;17(2):499-507.
  • Okada M, Yamane M, Yamamoto S, Otani S, Miyoshi K, Sugimoto S, Matsukawa A, Toyooka S, Oto T, Miyoshi S.; SPRED2 deficiency may lead to lung ischemia-reperfusion injury via ERK1/2 signaling pathway activation. ; Surg Today.;48(12):1089-1095..
  • Takahashi Y, Shien K, Tomida S, Oda S, Matsubara T, Sato H, Suzawa K, Kurihara E, Ogoshi Y, Namba K, Yoshioka T, Torigoe H, Yamamoto H, Soh J, Toyooka S.; Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis. ; Cancer Sci.;109(11):3634-3642.
  • Kubo T, Ninomiya T, Hotta K, Kozuki T, Toyooka S, Okada H, Fujiwara T, Udono H, Kiura K.; Study Protocol: Phase-Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors. ; Clin Lung Cancer.;19(6):e861-e864.
  • Tanaka S, Sugimoto S, Kurosaki T, Miyoshi K, Otani S, Suzawa K, Hashida S, Yamane M, Oto T, Toyooka S.; Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation. ; Sci Rep.;8(1):15366.
  • Sato H, Yamamoto H, Sakaguchi M, Shien K, Tomida S, Shien T, Ikeda H, Hatono M, Torigoe H, Namba K, Yoshioka T, Kurihara E, Ogoshi Y, Takahashi Y, Soh J, Toyooka S.; Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer. ; Cancer Sci.;109(10):3183-3196.
  • Kato Y, Ninomiya K, Ohashi K, Tomida S, Makimoto G, Watanabe H, Kudo K, Matsumoto S, Umemura S, Goto K, Ichihara E, Ninomiya T, Kubo T, Sato A, Hotta K, Tabata M, Toyooka S, Maeda Y, Kiura K.; Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions. ; Cancer Sci.;109(10):3149-3158.
  • Kurosaki T, Miyoshi K, Otani S, Imanishi K, Sugimoto S, Yamane M, Kobayashi M, Toyooka S, Oto T.; Low-risk donor lungs optimize the post-lung transplant outcome for high lung allocation score patients. ; Surg Today.;48(10):928-935.
  • Nakamura K, Sakaguchi M, Matsubara H, Akagi S, Sarashina T, Ejiri K, Akazawa K, Kondo M, Nakagawa K, Yoshida M, Miyoshi T, Ogo T, Oto T, Toyooka S, Higashimoto Y, Fukami K, Ito H.; Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension. ; PLoS One.;13(9):e0203046.
  • Habu T, Soh J, Toji T, Shien K, Niman E, Namba K, Sato H, Yamamoto H, Sugimoto S, Yamane M, Toyooka S.; Myoepithelioma occurring in the posterior mediastinum harboring EWSR1 rearrangement: a case report. ; Jpn J Clin Oncol.;48(9):851-854..
  • Sugimoto S, Yamane M, Otani S, Kurosaki T, Okahara S, Hikasa Y, Toyooka S, Kobayashi M, Oto T.; Airway complications have a greater impact on the outcomes of living-donor lobar lung transplantation recipients than cadaveric lung transplantation recipients. ; Surg Today.;48(9):848-855.
  • Yamamoto H, Yatabe Y, Toyooka S.; Inherited lung cancer syndromes targeting never smokers. ; Transl Lung Cancer Res.;7(4):498-504.
  • Ruma IMW, Kinoshita R, Tomonobu N, Inoue Y, Kondo E, Yamauchi A, Sato H, Sumardika IW, Chen Y, Yamamoto KI, Murata H, Toyooka S, Nishibori M, Sakaguchi M.; Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms. ; Cancers (Basel).;10(7). pii: E239.
  • Sato H, Soh J, Hotta K, Katsui K, Kanazawa S, Kiura K, Toyooka S.; Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion? ; Ann Thorac Cardiovasc Surg.;24(3):131-138.
  • Torigoe H, Yamamoto H, Sakaguchi M, Youyi C, Namba K, Sato H, Shien K, Soh J, Suzawa K, Tomida S, Tsukuda K, Miyoshi S, Toyooka S.; Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR. ; Carcinogenesis.;39(5):719-727.
  • Torigoe H, Shien K, Takeda T, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, Soh J, Sakaguchi M, Tomida S, Tsukuda K, Miyoshi S, Toyooka S.; Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations. ; Cancer Sci.;109(5):1493-1502.
  • Iguchi T, Hiraki T, Matsui Y, Fujiwara H, Masaoka Y, Tanaka T, Sato T, Gobara H, Toyooka S, Kanazawa S.; Preoperative short hookwire placement for small pulmonary lesions: evaluation of technical success and risk factors for initial placement failure. ; Eur Radiol.;28(5):2194-2202.
  • Toyooka S, Okumura N, Nakamura H, Nakata M, Yamashita M, Tada H, Kajiwara S, Watanabe N, Okada M, Sakamoto J, Aoe M, Soh J, Miyoshi S, Hotta K, Matsuo K, Date H.; A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer. ; J Thorac Oncol.;13(5):699-706.
  • Sumardika IW, Youyi C, Kondo E, Inoue Y, Ruma IMW, Murata H, Kinoshita R, Yamamoto KI, Tomida S, Shien K, Sato H, Yamauchi A, Futami J, Putranto EW, Hibino T, Toyooka S, Nishibori M, Sakaguchi M.; β-1,3-Galactosyl-O-Glycosyl-Glycoprotein β-1,6-N-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility. ; Oncol Res.;26(3):431-444.
  • Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S.; Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer. ; Cancer Sci.;109(4):1166-1176.
  • Tomida S, Toyooka S.; [Clinical Implementation of Precision Medicine]. ; Gan To Kagaku Ryoho.;45(4):601-604.
  • Miura A, Soh J, Shien K, Yamamoto H, Toyooka S.; [Induction Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer]. ; Kyobu Geka.;71(4):270-277.
  • Miyajima M, Watanabe A, Sato T, Teramukai S, Ebina M, Kishi K, Sugiyama Y, Kondo H, Kobayashi S, Takahashi Y, Ito H, Yamamoto R, Sawada S, Fujimori H, Okabe K, Arikura J, Shintani Y, Nakamura H, Toyooka S, Hasumi T, Watanabe T, Hata Y, Iwata H, Aoki M, Funai K, Inoue S, Kawashima O, Iida T, Date H..; What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection? ; Surg Today.;48(4):404-415.
  • Takagi M, Demizu Y, Nagano F, Terashima K, Fujii O, Jin D, Mima M, Niwa Y, Katsui K, Suga M, Yamashita T, Akagi T, Sakata KI, Fuwa N, Okimoto T.; Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study. ; Radiat Oncol. Nov 26;13(1):232.

2017

  • Mitsui Y, Sadahira T, Araki M, Wada K, Tanimoto R, Ariyoshi Y, Kobayashi Y,Watanabe M, Watanabe T, Nasu Y.. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy. Clin Exp Nephrol.;22(2):453-458.
  • Kobayashi T, Kanao K, Araki M, Terada N, Kobayashi Y, Sawada A, Inoue T, EbaraS, Watanabe T, Kamba T, Sumitomo M, Nasu Y., Ogawa O. Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer. Int J Clin Oncol. r;23(2):347-352.
  • Matsubara N, Nagamori S, Wakumoto Y, Uemura H, Kimura G, Yokomizo A, Kikukawa H, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y., Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Tsutsui H, Uemura H. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer. Int J Clin Oncol.;23(1):173-180. 
  • Sadahira T, Wada K, Araki M, Ishii A, Watanabe T, Nasu Y., Tsugawa M, Takenaka T, Nasu Y., Kumon H. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy. Int J Urol.;24(12):842-847.
  • Xu J, Sadahira T, Kinoshita R, Li SA, Huang P, Wada K, Araki M, Ochiai K, Noguchi H, Sakaguchi M, Nasu Y., Watanabe M. Exogenous DKK-3/REIC inhibits Wnt/β-catenin signaling and cell proliferation in human kidney cancer KPK1. Oncol Lett.;14(5):5638-5642. 
  • Mitsui Y, Wada K, Araki M, Yoshioka T, Ariyoshi Y, Nishimura S, Kobayashi Y, Sasaki K, Watanabe T, Nasu Y.. Ureterolithotripsy for a Ureteral Calculus at the Ureteroureterostomy of a Renal-transplant Recipient. Acta Med Okayama.;71(5):449-452.
  • 7Matsubara T, Tomida S, Soh J, Uwabo T, Mori Y, Morita M, Nasu Y., Kanazawa S., Toyooka S.. Effects of Cold Ischemia on RNA Stability and Quality of Lung Tissues Based on Standard PREanalytical Code Categorization. Biopreserv Biobank.;15(5):484-486.
  • 8Sawahara H, Shiraha H, Uchida D, Kato H, Kato R, Oyama A, Nagahara T, Iwamuro M, Horiguchi S, Tsutsumi K, Mandai M, Mimura T, Wada N, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Watanabe M, Sakaguchi M, Takaki A, Nouso K, Yagi T, Nasu Y., Kumon H, Okada H. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma. J Gastroenterol Hepatol.;32(10):1769-1777..
  • 9Horikawa Y, Watanabe M, Sadahira T, Ariyoshi Y, Kobayashi Y, Araki M, Wada K, Ochiai K, Li SA, Nasu Y.. Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells. Oncol Lett.;14(3):3223-3228.
  • Araki M, Wada K, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Yoshioka T, Ariyoshi Y, Fujio K, Takamoto A, Sugimoto M, Sasaki K, Kobayashi Y, Ebara S, Taninishi H, Amano H, Inui M, Watanabe M, Watanabe T, Nasu Y.. Robotic Renal Autotransplantation: First Case Outside of North America. Acta Med Okayama.;71(4):351-355.
  • Kai S, Wada K, Sadahira T, Araki M, Ishii A, Watanabe T, Monden K, Uno S, Araki T, Nasu Y.. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males. J Infect Chemother.;23(8):512-516.
  • Sakaguchi M, Sadahira T, Ueki H, Kinoshita R, Murata H, Yamamoto KI, Futami J, Nasu Y., Ochiai K, Kumon H, Huh NH, Watanabe M. Robust cancer-specific gene expression by a novel cassette with hTERT and CMV promoter elements. Oncol Rep.;38(2):1108-1114.
  • Yoshioka T, Araki M, Ariyoshi Y, Wada K, Tanaka N, Nasu Y.. Successful microscopic renal autotransplantation for left renal aneurysm associated with segmental arterial mediolysis. J Vasc Surg.;66(1):261-264.
  • Putranto EW, Kinoshita R, Watanabe M, Sadahira T, Murata H, Yamamoto KI, Futami J, Kataoka K, Inoue Y, Winarsa Ruma IM, Sumardika IW, Youyi C, Kubo M, Sakaguchi Y, Saito K, Nasu Y., Kumon H, Huh NH, Sakaguchi M. Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene. Oncol Lett.;14(1):1041-1048.
  • Sasaki K, Wada K, Araki M, Kobayashi Y, Sugimoto M, Ebara S, Watanabe T, Nasu Y.. Diagnostic Ureteroscopy for Cases Clinically Suspected of Carcinoma in Situ of the Upper Urinary Tract. Acta Med Okayama.;71(3):227-232.
  • Takamoto A, Araki M, Wada K, Sugimoto M, Kobayashi Y, Sasaki K, Watanabe T, Nasu Y.. A Combination Therapy of Partial Nephrectomy and Cryoablation Achieved Good Cancer Control and Renal Function in Bilateral Synchronous Renal Cell Carcinoma. Acta Med Okayama.;71(2):187-190.
  • Mori A, Watanabe M, Sadahira T, Kobayashi Y, Ariyoshi Y, Ueki H, Wada K, Ochiai K, Li SA, Nasu Y.. The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition. Acta Med Okayama.;71(2):135-142.
  • Ogawa N, Sato S, Ida K, Kato K, Ariyoshi Y, Wada K, Nasu Y., Kanazawa S.. Evaluation of Urinary Stone Composition and Differentiation between Urinary Stones and Phleboliths Using Single-source Dual-energy Computed Tomography. Acta Med Okayama.;71(2):91-96.
  • Sadahira T, Wada K, Ikawa K, Morikawa N, Kurahashi H, Yoshioka T, Ariyoshi Y, Kobayashi Y, Araki M, Ishii A, Watanabe M, Uehara S, Watanabe T, Nasu Y.. Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue. J Infect Chemother.;23(4):214-217.
  • Iguchi T, Hiraki T, Gobara H, Fujiwara H, Sakurai J, Matsui Y, Araki M, Nasu Y., Kanazawa S.. Value of percutaneous needle biopsy of small renal tumors in patients referred for cryoablation. Minim Invasive Ther Allied Technol.;26(2):86-91.
  • Otani Y, Ishida J, Kurozumi K, Oka T, Shimizu T, Tomita Y, Hattori Y, Uneda A, Matsumoto Y, Michiue H., Tomida S, Matsubara T, Ichikawa T, Date I.. PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma. Sci Rep.;7(1):7391.
  • Kamei R, Tanaka HY, Kawano T, Morii C, Tanaka S, Nishihara H, Iwata C, Kano M.R. Regulation of endothelial Fas expression as a mechanism of promotion of vascular integrity by mural cells in tumors. Cancer Sci.;108(5):1080-1088.
  • Matsusaki M, Komeda M, Mura S, Tanaka HY, Kano M.R, Couvreur P, Akashi M. Desmoplastic Reaction in 3D-Pancreatic Cancer Tissues Suppresses Molecular Permeability. Adv Healthc Mater.;6(15).
  • Takahashi N, Wei FY, Watanabe S, Hirayama M, Ohuchi Y, Fujimura A., Kaitsuka T, Ishii I, Sawa T, Nakayama H, Akaike T, Tomizawa K.. Reactive sulfur species regulate tRNA methylthiolation and contribute to insulin secretion. Nucleic Acids Res.;45(1):435-445. 
  • Asano K, Suzuki T, Saito A, Wei FY, Ikeuchi Y, Numata T, Tanaka R, Yamane Y, Yamamoto T, Goto T, Kishita Y, Murayama K, Ohtake A, Okazaki Y, Tomizawa K., Sakaguchi Y, Suzuki T. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. Nucleic Acids Res.;46(4):1565-1583.
  • Fakruddin M, Wei FY, Suzuki T, Asano K, Kaieda T, Omori A, Izumi R, Fujimura A., Kaitsuka T, Miyata K, Araki K, Oike Y, Scorrano L, Suzuki T, Tomizawa K.. Defective Mitochondrial tRNA Taurine Modification Activates Global Proteostress and Leads to Mitochondrial Disease. Cell Rep.;22(2):482-496.
  • Kaitsuka T, Kiyonari H, Shiraishi A, Tomizawa K., Matsushita M. Deletion of Long Isoform of Eukaryotic Elongation Factor 1Bδ Leads to Audiogenic Seizures and Aversive Stimulus-Induced Long-Lasting Activity Suppression in Mice. Front Mol Neurosci.;11:358.
  • Fakruddin M, Wei FY, Emura S, Matsuda S, Yasukawa T, Kang D, Tomizawa K.. Cdk5rap1-mediated 2-methylthio-N6-isopentenyladenosine modification is absent from nuclear-derived RNA species. Nucleic Acids Res.;45(20):11954-11961.
  • Akaike T, Ida T, Wei FY, Nishida M, Kumagai Y, Alam MM, Ihara H, Sawa T, Matsunaga T, Kasamatsu S, Nishimura A, Morita M, Tomizawa K., Nishimura A, Watanabe S, Inaba K, Shima H, Tanuma N, Jung M, Fujii S, Watanabe Y, Ohmuraya M, Nagy P, Feelisch M, Fukuto JM, Motohashi H. Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics. Nat Commun.;8(1):1177.
  • Saito M, Otsu W, Hsu KS, Chuang JZ, Yanagisawa T, Shieh V, Kaitsuka T, Wei FY, Tomizawa K., Sung CH. Tctex-1 controls ciliary resorption by regulating branched actin polymerization and endocytosis. EMBO Rep.;18(8):1460-1472.
  • Shibahara O, Watanabe M, Yamada S, Akehi M, Sasaki T, Akahoshi A, Hanada T, Hirano H, Nakatani S, Nishioka H, Takeuchi Y, Kakuta H.. Synthesis of (11)C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5 -carboxylic Acid (CBt-PMN) by Direct [(11)C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof. J Med Chem.;60(16):7139-7145.
  • Fujii U, Miyahara N, Taniguchi A, Oda N, Morichika D, Murakami E, Nakayama H, Waseda K, Kataoka M, Kakuta H., Tanimoto M, Kanehiro A. Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma. Respir Res.;18(1):23.
  • Ken-ichi Kudo, Tadashi HANAFUSA, Toshiro Ono, ; In vitro analysis of radioprotective effect of monoterpenes.  ; J Radioanal Nucl Chem
  • Takakura H, Domae S, Ono T., Sasaki A. The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma. Acta Med Okayama.;71(3):219-226.
  • Zaragoza FJ, Eichmann M, Flühs D, SAUERWEIN W.., Brualla L. Monte Carlo Estimation of Absorbed Dose Distributions Obtained from Heterogeneous (106)Ru Eye Plaques. Ocul Oncol Pathol.;3(3):204-209.
  • Ruhlmann V, Poeppel TD, Veit J, Nagarajah J, Umutlu L, Hoffmann TK, Bockisch A, Herrmann K, SAUERWEIN W... Diagnostic accuracy of (18)F-FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma. BMC Cancer.;17(1):887.
  • Watanabe H, Watanabe KS, Liu K, Hiramatsu S, Zeggar S, Katsuyama E, Tatebe N, Akahoshi A, Takenaka F, Hanada T, Akehi M, Sasaki T, Sada KE, Matsuura E, Nishibori M, Wada J. Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice. Mol Ther Methods Clin Dev.;6:31-39.
  • Sasaki T, Kobayashi K, Kita S, Kojima K, Hirano H, Shen L, Takenaka F, Kumon H, Matsuura E. In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β(2)-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging. Autoimmun Rev.;16(2):159-167.
  • Li X, Xu P, Wang C, Xu N, Xu A, Xu Y, Sadahira T, Araki M, Wada K, Matsuura E, Watanabe M, Zheng J, Sun P, Huang P, Nasu Y., Liu C. Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma. Oncotarget.;8(13):21177-21186. 
  • Li J, Xiu Z, Wang R, Yu C, Chi Y, Qin J, Fu C, Matsuura E, Liu Q. The lipid moiety 7-ketocholesteryl-9-carboxynonanoate mediates binding interaction of oxLDL to LOX-1 and upregulates ABCA1 expression through PPARγ. Life Sci.;177:27-40.
  • Hiraki T, Matsuno T, Kamegawa T, Komaki T, Sakurai J, Matsuura R, Yamaguchi T, Sasaki T, Iguchi T, Matsui Y, Gobara H, Kanazawa S.. Robotic Insertion of Various Ablation Needles Under Computed Tomography Guidance: Accuracy in Animal Experiments. Eur J Radiol.;105:162-167.
  • Hara T, Ogata T, Wada H, Yabuki T, Kanazawa S.. Prostate Cancer Detection with Multiparametric MRI: A Comparison of 1 M-Concentration Gadobutrol with 0.5 M-Concentration Gadolinium-Based Contrast Agents. Curr Urol.;11(4):201-205.
  • Oe H, Watanabe N, Miyoshi T, Osawa K, Akagi T, Kanazawa S., Ito H. Potential benefit of a simultaneous, side-by-side display of contrast MDCT and echocardiography over routine sequential imaging for assessment of adult congenital heart disease: A preliminary study. J Cardiol.;72(5):395-402.
  • Sato H, Soh J, Hotta K, Katsui K., Kanazawa S., Kiura K, Toyooka S.. Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion? Ann Thorac Cardiovasc Surg.;24(3):131-138.
  • Tanigawa N, Arai Y, Yamakado K, Aramaki T, Inaba Y, Kanazawa S., Matsui O, Miyazaki M, Kodama Y, Anai H, Hamanaka A. Phase I/II Study of Radiofrequency Ablation for Painful Bone Metastases: Japan Interventional Radiology in Oncology Study Group 0208. Cardiovasc Intervent Radiol.;41(7):1043-1048.
  • Yoshimura Y, Kuroda M, Sugiantoc I, Bamgbosec BO, Miyahara K, Ohmura Y, Kurozumi A, Matsushita T, Ohno S, Kanazawa S., Asaumi J. The Usefulness of Readout-Segmented Echo-Planar Imaging (RESOLVE) for Bio-phantom Imaging Using 3-Tesla Clinical MRI. Acta Med Okayama.;72(1):53-59.
  • Wang B, Li T, Niu Y, Xiang J, Cheng J, Liu B, Zhang H, Yan T, Kanazawa S., Wu J. Differences in neural responses to ipsilateral stimuli in wide-view fields between face- and house-selective areas. PLoS One.;13(2):e0192532.
  • Asano Y, Tada A, Shinya T, Masaoka Y, Iguchi T, Sato S, Kanazawa S.. Utility of second-generation single-energy metal artifact reduction in helical lung computed tomography for patients with pulmonary arteriovenous malformation after coil embolization. Jpn J Radiol.;36(4):285-294.
  • Komaki T, Hiraki T, Uka M, Fujiwara H, Iguchi T, Kanazawa S.. A Case of Stent Fracture After Transjugular Intrahepatic Portosystemic Shunt. Cardiovasc Intervent Radiol.;41(6):976-978.
  • Hara T, Ogata T, Wada H, Yabuki T, Kanazawa S.. Prostate Cancer Detection with Multiparametric MRI: A Comparison of 1 M-Concentration Gadobutrol with 0.5 M-Concentration Gadolinium-Based Contrast Agents. Curr Urol.;11(4):201-205.
  • Iguchi T, Hiraki T, Matsui Y, Fujiwara H, Masaoka Y, Tanaka T, Sato T, Gobara H, Toyooka S., Kanazawa S.. Preoperative short hookwire placement for small pulmonary lesions: evaluation of technical success and risk factors for initial placement failure. Eur Radiol.;28(5):2194-2202.
  • Yoshimura Y, Kuroda M, Sugiantoc I, Bamgbosec BO, Miyahara K, Ohmura Y, Kurozumi A, Matsushita T, Ohno S, Kanazawa S., Asaumi J. The Usefulness of Readout-Segmented Echo-Planar Imaging (RESOLVE) for Bio-phantom Imaging Using 3-Tesla Clinical MRI. Acta Med Okayama.;72(1):53-59.
  • Iguchi T, Hiraki T, Matsui Y, Fujiwara H, Sakurai J, Masaoka Y, Gobara H, Kanazawa S.. CT fluoroscopy-guided renal tumour cutting needle biopsy:retrospective evaluation of diagnostic yield, safety, and risk factors for diagnostic failure. Eur Radiol.;28(1):283-290.
  • Yoshio K, Mitsuhashi T, Wakita A, Kitayama T, Hisazumi K, Inoue D, Shiode T, Akaki S, Kanazawa S.. Plan quality comparison between 4-arc and 6-arc noncoplanar volumetric modulated arc stereotactic radiotherapy for the treatment of multiple brain metastases. Med Dosim. ;43(4):358-362.
  • Hiraki T, Kamegawa T, Matsuno T, Sakurai J, Kirita Y, Matsuura R, Yamaguchi T, Sasaki T, Mitsuhashi T, Komaki T, Masaoka Y, Matsui Y, Fujiwara H, Iguchi T, Gobara H, Kanazawa S.. Robotically Driven CT-guided Needle Insertion: Preliminary Results in Phantom and Animal Experiments. Radiology.;285(2):454-461.
  • Marukawa Y, Sato S, Tanaka T, Tada A, Kanie Y, Kanazawa S.. Evaluating Low-kV Dual-source CT Angiography by High-pitch Spiral Acquisition and Iterative Reconstruction in Pediatric Congenital Heart Disease Patients. Acta Med Okayama. ;71(5):407-412.
  • Kanie Y, Sato S, Tada A, Kanazawa S..; Image Quality of Coronary Arteries on Non-electrocardiography-gated High-Pitch Dual-Source Computed Tomography in Children with Congenital Heart Disease. ; Pediatr Cardiol.;38(7):1393-1399.
  • Sato H, Toyooka S., Soh J, Hotta K, Katsui K., Shien K, Yamamoto H, Oto T, Kanazawa S., Kiura K, Miyoshi S.; Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin. ; Ann Thorac Surg.;104(3):971-978.
  • Torigoe H, Soh J, Tomida S, Namba K, Sato H, Katsui K., Hotta K, Shien K, Yamamoto H, Yamane M, Kanazawa S., Kiura K, Miyoshi S, Toyooka S..; Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer. ; J Thorac Dis.;9(9):3076-3086.
  • Tada A, Sato S, Masaoka Y, Kanazawa S..; Imaging of the temporal bone in children using low-dose 320-row area detector computed tomography. ; J Med Imaging Radiat Oncol.;61(4):489-493.
  • Yodoya M, Hiraki T, Iguchi T, Fujiwara H, Matsui Y, Masaoka Y, Sakurai J, Mitsuhashi T, Gobara H, Kanazawa S..; Disappearance of Renal Cysts Included in Ice Ball During Cryoablation of Renal-Cell Carcinoma: A Potential Therapy for Symptomatic Renal Cysts? ; J Vasc Interv Radiol.;28(6):869-876.
  • Shirakawa Y, Noma K, Maeda N, Tanabe S, Kuroda S, Kagawa S, Katsui K., Katayama N, Kanazawa S., Fujiwara T.; Outcome of Radiation MOno T.herapy for High-risk Patients with Stage I Esophageal Cancer. ; Acta Med Okayama.;71(2):127-133.
  • Shinya T, Tanaka T, Soh J, Matsushita T, Sato S, Toyooka S., Yoshino T, Miyoshi S, Kanazawa S..; Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms. ; Acta Med Okayama.;71(2):105-112.
  • Hiramatsu M, Hishikawa T, Tokunaga K, Kidoya H, Nishihiro S, Haruma J, Shimizu T, Takasugi Y, Shinji Y, Sugiu K, Takakura N, Date I.; Combined gene therapy with vascular endothelial growth factor plus apelin in a chronic cerebral hypoperfusion model in rats ;  Journal of Neurosurgery 127(3):679-686
  • Yumoto T, Iida A, Tsukahara K, Naito H, Terado M, Sato K, Date I. Nakao A;  A successfully-treated case of penetrating facial trauma ;  International Journal of Case Reports and Images 8(2):120-123
  • Sato K, Tsunoda K, Yamashita T, Takemoto M, Hishikawa N, Ohta Y, Takahashi T, Nakashima I, Yasuhara T, Date I., Abe K;  A case of very long longitudinally extensive transverse myelitis (LETM) with necrotizing Vasculitis ;  Journal of the Neurological Sciences 373:152-154
  • Kin K, Yasuhara T, Kameda M, Agari T, Sasaki T, Morimoto J, Okazaki M, Umakoshi M, Kuwahara K, Kin I, Tajiri N, Date I.;  Hippocampal neurogenesis of Wistar Kyoto rats is congenitally impaired and correlated with stress resistance ;  Behavioural Brain Research 329:148-156
  • Sasada S, Agari T, Sasaki T, Kondo A, Shinko A, Wakamori T, Okazaki M, Kin I, Kuwahara K, Kameda M, Yasuhara T, Date I.;  Efficacy of fiber tractography in the stereotactic surgery of the thalamus for patients with essential tremor ;  Neurologica medico-chirurgica 57(8):392-401
  • Kameda M, Yamada S, Atsuchi M, Kimura T, Kazui H, Miyajima M, Mori E, Ishikawa M, Date I., SINPHONI and SINPHONI-2 investigators;  Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials ;  Acta Neurochirurgica (Wien) 159(6):995-1003
  • Kurozumi K, Kameda M, Ishida J, Date I.;  Simultaneous combination of electromagnetic navigation with visual evoked potential in endoscopic transsphenoidal surgery :clinical experience and technical considerations ;  Acta Neurochirurgica (Wien) 159(6):1043-1048
  • Kameda M, Takahara E, Kobayashi M, Sasaki K, Morihara R, Date I.;  Pregnancy and delivery after myelomeningocele repair, ventriculoperitoneal shunt implantation, and augmentation cystoplasty ;  Child's Nervous System 33(6):1015-1017
  • Kameda M, Otani Y, Ichikawa T, Shimada A, Ichimura K, Date I.;  Congenital glioblastoma with distinct clinical and molecular characteristics :case reports and a literature review ;  World Neurosurgery 101: 817.e5-817.e14
  • Okuma Y, Sugiu K, Hirotsune N, Hishikawa T, Muraoka K, Hiramatsu M, Nishino S, Date I.;  Post coiling syndrome might predict recurrence after coil embolization of unruptured cerebral aneurysms ;  Journal of Neuroendovascular Therapy 11(5):235-239
  • Hishikawa T, Date I.;  Unruptured cerebral aneurysms in elderly patients ;  Neurologica medico-chirurgica 57(6):247-252
  • Kidani N, Sugiu K, Hishikawa T, Hiramatsu M, Haruma J, Nishihiro S, Takahashi Y, Date I.;  De novo vertebral artery dissecting aneurysm after internal trapping of the contralateral vertebral artery ;  Acta Neurochirurgica 159(7):1329-1333
  • Kobayashi K, Akiyama T, Agari T, Sasaki T, Shibata T, Hanaoka Y, Akiyama M, Endoh F, Oka M, Date I.;  Significance of high-frequency electrical brain activity ;  Acta Medical Okayama 71(3):191-200
  • Yamada S, Ishikawa M, Miyajima M, Atsuchi M, Kimura T, Kazui H, Mori E, SINPHONI-2 investigators(Hashimoto M, Oligasa H, Yamamoto H, Arai H, Mori K, Nakamura S, Miki T, Ishii K, Miyake H, Kuwana N, Samejima N, Tokuda T, Nakajima M, Mase M, Mori S, Kajimoto Y, Nakayama E, Hirai O, Takeda M, Chang CC, Date I., Kameda M, Okada T, Hamada J, Watanabe M, Kajima M, Sunada S, Hirata Y);  Disease duration :the key to accurate CSF tap test in iNPH ;  Acta Neurologica Scandinavia 135(2):189-196
  • Toyoshima A, Yasuhara T, Date I.;  Mesenchymal stem cell therapy for ischemic stroke ;  Acta Medica Okayama 71(4):263-268
  • Otani Y, Ishida J, Kurozumi K, Oka T, Shimizu T, Tomita Y, Hattori Y, Uneda A, Matsumoto Y, Michiue H., Tomida S, Ichikawa T, Date I.;  PIK3R1Met326lle germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma ;  Scientific Reports 7(1):7391
  • Yasuhara T, Date I., Liska GL, Kaneko Y, Vale FL;  Translating regenerative medicine techniques for the treatment of epilepsy ;  Brain Circulation 3(3):156-162
  • Nakano Y, Nomura E, Hiramatsu M, Takemoto M, Sato K, Hishikawa N, Yamashita T, Ohta Y, Sugiu K, Date I., Abe K;  Dissociated recovery between dementia and parkinsonism by transvenous embolization of recurrent dural arteriovenous fistula ;  Neurology and Clinical Neuroscience 5:159-161
  • Makimoto G, Kubo T, Oze I, Ohashi K, Hotta K, Tabata M, Soh J, Toyooka S., Katsui K., Takigawa N, Tanimoto M, Kiura K.; Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery. ; Jpn J Clin Oncol. ;48(3):287-290.
  • Hotta K, Aoe K, Kozuki T, Ohashi K, Ninomiya K, Ichihara E, Kubo T, Ninomiya T, Chikamori K, Harada D, Nogami N, Hirata T, Hinotsu S, Toyooka S., Kiura K.; A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non-Small Cell Lung Cancer. ; J Thorac Oncol. ;13(2):273-279.
  • Yamamoto H, Toyooka S., Ninomiya T, Matsumoto S, Kanai M, Tomida S, Kiura K, Muto M, Suzawa K, Desmeules P, Kris MG, Li BT, Ladanyi M.; Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E. ; Oncologist. ;23(2):150-154.
  • Sato H, Sakaguchi M, Yamamoto H, Tomida S, Aoe K, Shien K, Yoshioka T, Namba K, Torigoe H, Soh J, Tsukuda K, Tao H, Okabe K, Miyoshi S, Pass HI, Toyooka S..; Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma. ; Oncogenesis. ;7(1):11.
  • Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, Chida M, Sato M, Toyooka S., Yoshida K, Okada Y, Sato Y, Okada M, Okumura M, Chihara K, Fukuchi E, Miyata H.; Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78594 patients during 2014-2015. ; Eur J Cardiothorac Surg.;52(6):1182-1189.
  • Tao H, Soh J, Yamamoto H, Fujiwara T, Ueno T, Hayama M, Okazaki M, Sugimoto R, Yamashita M, Sano Y, Okabe K, Matsuura M, Kataoka K, Moriyama S, Toyooka S., Miyoshi S.; Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung. ; J Thorac Dis. ;9(11):4325-4335. .
  • Yamamoto H, Sugimoto S, Otani S, Toyooka S..; Postoperative pyoderma gangrenosum exacerbated by granulocyte-colony stimulating factor after lung cancer surgery. ; Jpn J Clin Oncol.  1;47(10):991-992.
  • Shien K, Papadimitrakopoulou VA, Ruder D, Behrens C, Shen L, Kalhor N, Song J, Lee JJ, Wang J, Tang X, Herbst RS, Toyooka S., Girard L, Minna JD, Kurie JM, Wistuba II, Izzo JG.; JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer. ; Mol Cancer Ther. ;16(10):2234-2245.
  • Chen H, Shien K, Suzawa K, Tsukuda K, Tomida S, Sato H, Torigoe H, Watanabe M, Namba K, Yamamoto H, Soh J, Asano H, Miyoshi S, Toyooka S..; Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer. ; Oncol Lett.;14(4):4349-4354.
  • Ito S, Kamoto Y, Sakai A, Sasai K, Hayashi T, Toyooka S., Katayama H.; Unique circulating microRNAs in relation to EGFR mutation status in Japanese smoker male with lung adenocarcinoma. ; Oncotarget. ;8(70):114685-114697.
  • Watanabe M, Hashida S, Yamamoto H, Matsubara T, Ohtsuka T, Suzawa K, Maki Y, Soh J, Asano H, Tsukuda K, Toyooka S., Miyoshi S.; Estimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methods. ; Exp Ther Med. ;14(3):2683-2688.
  • Kawana S, Yamamoto H, Maki Y, Sugimoto S, Toyooka S., Miyoshi S.; Reconstruction of Anterior Chest Wall with Polypropylene Mesh: Two Primary Sternal Chondrosarcoma Cases. ; Acta Med Okayama. ;71(3):259-262.
  • Tanaka N, Toyooka S., Soh J, Kubo T, Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, Asano H, Tsukuda K, Aoe K, Miyoshi S.; Erratum to Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer [Lung Cancer 76 (1) (2012) 32-38]. ; Lung Cancer.;108:254-255.
  • Shien K, Toyooka S., Soh J, Yamamoto H, Miyoshi S.; Is tumor location an independent prognostic factor in locally advanced non-small cell lung cancer treated with trimodality therapy? ; J Thorac Dis.;9(5):E489-E491.
  • Suzawa K, Yamamoto H, Ohashi K, Hashida S, Tomida S, Kubo T, Maki Y, Soh J, Tsukuda K, Kiura K, Miyoshi S, Toyooka S..; Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system. ; Oncol Rep.;37(5):3100-3106.
  • Maki Y, Toyooka S., Soh J, Yamamoto H, Sugimoto S, Yamane M, Oto T, Miyoshi S.; Early postoperative complications after middle lobe-preserving surgery for secondary lung cancer. ; Surg Today.;47(5):601-605.
  • Okumura N, Sonobe M, Okabe K, Nakamura H, Kataoka M, Yamashita M, Nakata M, Kataoka K, Yamashita Y, Soh J, Yoshioka H, Hotta K, Matsuo K, Sakamoto J, Toyooka S., Date H.; Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001. ; Int J Clin Oncol. ;22(2):274-282.
  • Jingu K, Niibe Y, Yamashita H, Katsui K., Matsumoto T, Nishina T, Terahara A.; Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study. ; Radiat Oncol. ;12(1):146.
  • Matsuzaki H, Tanaka-Matsuzaki K, Miyazaki F, Aoyama H, Ihara H, Katayama N, Katsui K., Himei K, Takeuchi T, Onoda T, Kimata Y, Asaumi JI.; The role of dentistry other than oral care in patients undergoing radiotherapy for head and neck cancer. ; Jpn Dent Sci Rev. ;53(2):46-52.

SERIES OF INVITED LECTERS

OPEN

  • The First Lecture

    April 11, 2017

    ① BNCTとは ② PETの意義 ③ 脳腫瘍に対するBNCT

    Dr. Shinichi Miyatake
    Professor, Department of Neurosurgery, Cancer Center of Osaka Medical College

  • The Second Lecture

    May 9, 2017

    「 日本のBNCT展望 ―究極の癌治療を目指して― 」

    Dr. Junichi Hiratsuka
    Professor, Department of Radiation Oncology
    Kawasaki Medical School, School of Medicine, Department of Medicine

  • The Third Lecture

    June 9, 2017

    「 BNCTの生物特性の理解にむけて 」

    Dr. Mitsuko Masutani
    Professor, Department of Frontier Life Sciences
    Nagasaki University Graduate School of Biomedical Sciences

  • The Fourth Lecture

    July 4, 2017

    「 BNCTの現状と将来展望 」

    Dr. Minoru Suzuki
    Professor, Division of Particle Radiation Oncology Particle Radiation Oncology Research Center,
    Research Reactor Institute, Kyoto University

  • The Fifth Lecture

    August 3, 2017

    「 ホウ素を用いてがんに挑む 」

    Dr. Hiroyuki Nakamura
    Professor, Institute of Innovative Research, Tokyo Institute of Technology, Laboratory for Chemistry and Life Science

  • The Sixth Lecture

    October 12, 2017

    「 国際原子力機関 IAEAとの連携の進歩状況について 」

    Dr. Hideki Matsui
    Professor, Department of Physiology.
    Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences